NCCAM meeting
This article was originally published in The Tan Sheet
Executive Summary
Center's National Advisory Council for Complementary & Alternative Medicine will convene for an open meeting June 4 beginning at 1 p.m. to hear a report from the Cancer Working Group and an overview of National Center for Health Statistics, in addition to updates on co-sponsorship of program announcements. Meeting will take place at the Natcher Conference Center, 9000 Rockville Pike, Bethesda, Md...
You may also be interested in...
QUOTED. 19 April 2021. Jeff Shuren & William Maisel
Two top officials in the US FDA’s device center are warning of delays in the agency’s review of submissions for new products that aren’t directly tied to the coronavirus pandemic.
Breakthrough Therapy Designations At US FDA Stay Sluggish In 2021
With 12 new BTDs announced so far this year, 2021 is on pace to match the COVID-19-depressed total number of designations in 2020. Here’s a breakdown of the candidates that have received the designation.
Half Of US FDA’s Breakthrough Therapy Designations Have Resulted In Approval
Popular expedited review program results in a higher approval rate than the related fast track designation, but the COVID-19 era is seeing a drop in designations and a rise in complete response letters for BTD programs.